Back to Search
Start Over
Pre- and postoperative need for pituitary hormone replacement in non-adenomatous sellar and parasellar lesions: importance of the sellar encroachment score
- Source :
- Waqar, M, Rampersad, S, Bennett, D, Kearney, T & Gnanalingham, K K 2020, ' Pre-and postoperative need for pituitary hormone replacement in non-adenomatous sellar and parasellar lesions: importance of the sellar encroachment score ', Acta Neurochirurgica . https://doi.org/10.1007/s00701-020-04440-4, Acta Neurochirurgica
- Publication Year :
- 2020
-
Abstract
- Background Pre-/postoperative pituitary endocrine deficiencies in patients with sellar/parasellar non-adenomatous lesions are poorly described and studies have not considered the effect of sellar invasion on endocrine outcome. The aim of this study was to relate the need for pituitary hormone replacement pre-/postoperatively, with sellar invasion, in non-adenomatous sellar/parasellar lesions. Methods Single-centre review of adults with histologically confirmed non-adenomatous sellar/parasellar lesion and follow-up ≥ 3 months or until postop radiotherapy. Pituitary dysfunction was defined by hormone replacement. The sellar encroachment score (0–6) was calculated as the sum of the thirds of radiological encroachment into the sellar region in the coronal and sagittal planes. Multivariate analysis with binary logistic regression was used to determine factors associated with pituitary hormone replacement. Results One hundred and seventeen patients were included with a median age of 49 years (range 16–84 years) and median follow-up of 13 months. Surgery was trans-sphenoidal (53%), trans-cranial (36%) or a combination (11%). The commonest histology types were meningioma (n = 33, 28%) and craniopharyngioma (n = 20, 17%). The median sellar encroachment score was 6 (range 0–6). Most (n = 86, 74%) did not require pituitary hormone replacement preoperatively. The need for pituitary hormones increased after surgery in 41 (35%) patients. In multivariate analysis, the sellar encroachment score was the only factor predictive of pre- (OR = 2.6, 95% CI = 1.2–5.5; p = 0.01) and postoperative risk of new pituitary hormone replacement (OR = 4.1, 95% CI = 1.7–10.1, p = 0.002). Conclusion A significant proportion of these patients present with need for pituitary hormone replacement that may worsen postoperatively. The degree of sellar encroachment is predictive of pituitary hormone replacement status pre-/postoperatively.
- Subjects :
- Adult
Male
medicine.medical_specialty
Encroachment score
Adolescent
Hormone Replacement Therapy
medicine.medical_treatment
030209 endocrinology & metabolism
Meningioma
03 medical and health sciences
Craniopharyngioma
Young Adult
0302 clinical medicine
Sphenoid Bone
medicine
Endocrine system
Humans
Pituitary Neoplasms
Sella Turcica
Prospective Studies
Neuroradiology
Aged
Aged, 80 and over
Postoperative Care
Sellar region
medicine.diagnostic_test
business.industry
Original Article - Pituitaries
Skull
Interventional radiology
Middle Aged
medicine.disease
Combined Modality Therapy
Magnetic Resonance Imaging
Hormones
Surgery
Radiation therapy
Non-adenomatous
Pituitary Hormones
Pituitary
Female
Neurology (clinical)
Neurosurgery
business
030217 neurology & neurosurgery
Hormone
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Journal :
- Waqar, M, Rampersad, S, Bennett, D, Kearney, T & Gnanalingham, K K 2020, ' Pre-and postoperative need for pituitary hormone replacement in non-adenomatous sellar and parasellar lesions: importance of the sellar encroachment score ', Acta Neurochirurgica . https://doi.org/10.1007/s00701-020-04440-4, Acta Neurochirurgica
- Accession number :
- edsair.doi.dedup.....364f44ac35b270f3ffd8070f5828f7df
- Full Text :
- https://doi.org/10.1007/s00701-020-04440-4